**Core Concept**
Central precocious puberty (CPP) in girls refers to the premature activation of the hypothalamic-pituitary-gonadal axis, leading to the onset of pubertal changes before the age of 8. This condition is characterized by the early activation of the hypothalamic secretion of gonadotropin-releasing hormone (GnRH), which in turn stimulates the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), resulting in the premature growth and development of sexual characteristics.

**Why the Correct Answer is Right**
The correct answer, **Idiopathic**, accounts for approximately 80-90% of cases of central precocious puberty in girls. In these cases, the exact cause of the premature activation of the hypothalamic-pituitary-gonadal axis remains unknown. However, it is believed that the premature activation of GnRH secretion may be due to an abnormality in the hypothalamic-pituitary-gonadal axis, which can be caused by a variety of factors, including genetic mutations, environmental factors, or other underlying conditions.

**Why Each Wrong Option is Incorrect**
**Option A:** Exogenous estrogen refers to the administration of estrogen from an external source, which can cause peripheral precocious puberty, not central precocious puberty. Central precocious puberty is characterized by the premature activation of the hypothalamic-pituitary-gonadal axis, whereas peripheral precocious puberty is caused by the premature activation of the gonads.
**Option C:** CNS tumor can cause central precocious puberty, but it is not the most common cause. CNS tumors can disrupt the normal functioning of the hypothalamic-pituitary-gonadal axis, leading to the premature activation of GnRH secretion.
**Option D:** Hypothyroidism can cause a variety of symptoms, including growth and developmental abnormalities, but it is not a common cause of central precocious puberty in girls.

**Clinical Pearl / High-Yield Fact**
It's essential to differentiate between central and peripheral precocious puberty, as the treatment approaches differ significantly. Central precocious puberty is treated with GnRH agonists, which suppress the premature activation of the hypothalamic-pituitary-gonadal axis, whereas peripheral precocious puberty is treated with medications that block the effects of estrogen or testosterone.

**✓ Correct Answer: B. Idiopathic. Idiopathic central precocious puberty accounts for approximately 80-90% of cases in girls.**